Evidence map›Paper›PMID 31832823›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Effects of age and gender in patients receiving doses of opioids for breakthrough pain proportional to background opioid doses.

Sebastiano Mercadante, Vincenzo Restivo, Alessandra Casuccio

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sebastiano MercadanteAnesthesia & Intensive care and Pain relief & Supportive care, La Maddalena Cancer Center, Palermo, Italy. terapiadeldolore@lamaddalenanet.it.
Vincenzo RestivoDepartment of Health Promotion, Mother-Child Care, Internal Medicine and Excellence Specialist Medicine 'G D'Alessandro', University of Palermo, Palermo, Italy.
Alessandra CasuccioDepartment of Health Promotion, Mother-Child Care, Internal Medicine and Excellence Specialist Medicine 'G D'Alessandro', University of Palermo, Palermo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo identify the role of age and gender in analgesic and adverse effects after administering fentanyl products for breakthrough pain (BT), given in doses proportional to opioid doses given for background pain.

methodsData from nine studies, in which patients with BP were given fentanyl products in doses proportional to their basal opioid regimen, were analyzed.

resultsA total 462 patients presenting 1905 episodes of BP were included in this analysis. In older patients, the decrease in pain intensity was more pronounced 15 min after administration of a BP medication. No gender differences were found. No significant differences in frequency and intensity of adverse effects for age and gender were found.

conclusionFentanyl products given for BP in doses proportional to background opioid regimen were more effective in older patients without adding risks of adverse effects. Gender did not influence analgesia and adverse effects of fentanyl products.

Indexed as

AgedAge FactorsAnalgesics, OpioidBreakthrough PainFemaleGender IdentityHumansMalePain MeasurementTreatment OutcomeAnalgesics, OpioidAgeBreakthrough painCancer painFentanylGender

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.